Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

BMC Cancer

Table 2 Predictors of Intentions to use Genomic Tumor Tests in the Next 12 Months

	Factor¹	95% CI²	p-value
Demographic Variables
Gender
Female	–	–
Male	1.72	0.98, 3.03	0.061
Years since medical school	1.04	1.01, 1.07	0.020
Practice Size (Number of oncology physicians)	0.99	0.92, 1.07	0.8
Rural practice location	0.66	0.34, 1.26	0.2
Average number of newly diagnosed patients each month	1.01	0.98, 1.05	0.3
Psychological Variables
Attitudes Summary Score	1.79	0.87, 3.68	0.11
Confidence Summary Score - Internal	2.07	1.24, 3.48	0.007
Confidence Summary Score - External	0.64	0.38, 1.08	0.094
Barriers Summary Score	1.88	1.07, 3.32	0.030

¹ Factor = exponetiated regression coefficient; every unit increase in the predictor variable is associated with a multiplicative effect of the coefficient on the number of GTT orders in the next 12 months
² CI Confidence Interval
N = 48 due to some participants were missing data (see Table 1)

ISSN: 1471-2407